Efficacy News and Research

RSS
Cancer Research Technology to present discovery updates at BioEurope 2006

Cancer Research Technology to present discovery updates at BioEurope 2006

The lifetime cost of current HIV care in the United States

The lifetime cost of current HIV care in the United States

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

Acupuncture in patients with osteoarthritis of the knee or hip

Acupuncture in patients with osteoarthritis of the knee or hip

Turmeric for prevention of rheumatoid arthritis and osteoporosis

Turmeric for prevention of rheumatoid arthritis and osteoporosis

The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of type II diabetes

The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of type II diabetes

Effective test for screening Huntington's disease drugs

Effective test for screening Huntington's disease drugs

Confusion abounds on how to treat the menopause

Confusion abounds on how to treat the menopause

DIY cure for tennis elbow

DIY cure for tennis elbow

New study emphasizes the importance of metabolomics to the advent of personalized medicine

New study emphasizes the importance of metabolomics to the advent of personalized medicine

Umbrella-like valve may help patients with emphysema breathe easier

Umbrella-like valve may help patients with emphysema breathe easier

New biologic treatment for tennis elbow

New biologic treatment for tennis elbow

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

FDA approves Omnaris, new hay fever drug

FDA approves Omnaris, new hay fever drug

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

FDA advisory panel recommends adding warning label to Tamoxifen

FDA advisory panel recommends adding warning label to Tamoxifen

NicOx announces EMEA approval of Naproxcinod study plan

NicOx announces EMEA approval of Naproxcinod study plan

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

Ho Chi Minh City to expand access to HIV/AIDS treatment for pregnant women

Ho Chi Minh City to expand access to HIV/AIDS treatment for pregnant women

Temperature-sensitive nanoparticle boosts drug antitumor activity

Temperature-sensitive nanoparticle boosts drug antitumor activity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.